Equity Research. Bank of the Ozarks, Inc. (OZRK-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation

Size: px
Start display at page:

Download "Equity Research. Bank of the Ozarks, Inc. (OZRK-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation"

Transcription

1 Equity Research July 14, 2006 Scott A. Jaggers, CFA North Wacker Drive Chicago, IL Bank of the Ozarks, Inc. (OZRK-NSDQ) Current Recommendation Hold Prior Recommendation Sell Date of Last Change 05/23/2006 Current Price (07/13/06) $30.02 Six-Month Target Price $32.00 SUMMARY DATA 52-Week High $ Week Low $30.02 One-Year Return (%) Beta 0.42 Average Daily Volume (sh) 72,131 Shares Outstanding (mil) 17 Market Capitalization ($mil) $502 Short Interest Ratio (days) Institutional Ownership (%) 62 Insider Ownership (%) 32 Annual Cash Dividend $0.40 Dividend Yield (%) Yr. Historical Growth Rates Sales (%) 17.6 Earnings Per Share (%) 32.8 Dividend (%) 31.7 P/E using TTM EPS 15.4 P/E using 2006 Estimate 15.1 P/E using 2007 Estimate 12.7 Zacks Rank 4 OUTLOOK OZRK hosted a conference call this morning after its earnings release last night. Nothing in the call changed our view relative to what we discussed in our Note. Management did clarify that there have been no bonus accruals so far in The quarter was solid (EPS was $0.02 better than our estimate), but not quite as strong as the headline implies. NII was below our projections, owing to a 23 bp decrease in NIM. The surprise came on the expense side, as expected growth from new branches and new hires was not evident. Our near-term estimates are little-changed, while 07 is coming down marginally. Our price target is falling in line with lower industry multiples overall. We view the $0.40 annual dividend as secure. Risk Level Below Avg. Type of Stock Small-Growth Industry Banks-Southeast Zacks Rank in Industry 82 of 105 ZACKS ESTIMATES Revenue (in millions of $) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) A 20 A 21 A 20 A 79 A A 22 A 23 A 23 A 88 A A 23 A 24 E 25 E 96 E E 28 E 29 E 31 E 114 E Earnings Per Share (EPS is operating earnings before non recurring items) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) 2004 $0.36 A $0.38 A $0.40 A $0.42 A $1.56 A 2005 $0.44 A $0.46 A $0.48 A $0.50 A $1.88 A 2006 $0.50 A $0.47 A $0.49 E $0.53 E $1.99 E 2007 $0.53 E $0.57 E $0.61 E $0.65 E $2.36 E Zacks Projected EPS Growth Rate - Next 5 Years % 14 Consensus Projected EPS Growth - Next 5 Years % Copyright 2006, Zacks Investment Research. All Rights Reserved.

2 OVERVIEW Headquartered in Little Rock, AR, Bank of the Ozarks, Inc. (OZRK) is the holding company for statechartered Bank of the Ozarks. OZRK provides a range of retail and commercial banking services through 56 full-service offices in Arkansas and three in Texas, plus three loan production offices in Arkansas and North Carolina. OZRK continues to grow primarily through a de novo branching strategy which it initiated in Expansion plans for 2006 include a record 12 new offices. Management is clearly focused on growth, but with an eye toward profitability. OZRK operates a fairly traditional banking model, deriving most of its revenue (79% in 2005) from spread-based sources. The loan portfolio is somewhat focused on real estate (82% at March 31), with the balance made up primarily of commercial / industrial, agricultural and consumer loans. The securities portfolio has been relatively steady at 25-30% of average earning assets in recent years (30% in Q2), which is a bit higher than necessary in our view, and helps explain the company s high returns. Noninterest-bearing and other low-cost deposits funded 33% of average earning assets in Q2, with time deposits and borrowing funding 51% and 18%, respectively. At June 30, OZRK had $2.4 billion in assets, $1.6 Bn in loans and leases, and $1.8 Bn in deposits. RECENT NEWS OZRK announced 2 nd quarter results on July 13. Net income was $7.9 million, or $0.47 per diluted share (two cents better than our estimate and a penny ahead of consensus). The quarter was relatively solid in our view, but not quite as strong as the headline implies. Management had seemed to imply previously that expense growth would be high, and we had attempted to adjust our forecast accordingly. In the end, though, both compensation and non-comp expenses were down sequentially, more in line with where we had been previously. Much of this year s spending is discretionary and lumpy, based on new branches and new hires. Our thinking at this time is that related spending has likely just been postponed, not eliminated, and we expect expense growth in each of the next two quarters. As for revenue, net interest income came in below our projections, rising only 1.7% sequentially, as a 7.4% increase in average loans was significantly offset by a 23 bp decrease in the margin (to 3.61%). Non-interest income was basically in line, as was the provision. Our near-term estimates are virtually unchanged at this time, while 07 figures are coming down slightly. Tax-equivalent net interest income increased by 1.7% sequentially (6.8% year-on-year) to $19.1 Mn, as 7.0% growth in average earning assets and a longer quarter were partially offset by a 23 bp drop in net interest margin (to 3.61%). Further margin deterioration remains a possibility, though the magnitude should be less than in recent quarters (although we said the same thing last quarter). Average loans and leases grew a strong 7.4% sequentially following their weakest quarterly showing in several years in Q1. Average deposits were up 9.3% sequentially (25.0% year-on-year), including nearly 8.5% growth in low-cost deposits. ROA and ROE fell noticeably on a GAAP basis, after last quarter s shortfalls were masked by huge securities gains. Credit quality remained outstanding, with net charge-offs annualizing at 0.09% in Q2 (down 1 bp sequentially) and non-performing loans checking in at 0.18% of total loans (down 6 bps). Capital remained solid, though tangible equity took a bit of a nosedive, falling 63 bps sequentially 5.9% of tangible assets. No detail was provided, but the culprit was most likely unrealized securities losses (the portfolio remains large at 30% of average earning assets in Q2). VALUATION OZRK currently trades at 14.4 times the consensus forward estimate (versus 15.9x at the time of our last full report), in line with the peer group median (vs. a 5% premium at that time). The premium is higher Zacks Investment Research Page 2

3 versus its southeastern peers, which have a lower expected growth rate (8.0% vs. 10%) and now trade at a median of 13.8 times forward estimates (vs x in mid-april). On a price-to-book basis, the shares trade at a 42% premium to the peer median, vs. a 61% premium previously. Current pricing continues to look interesting on a P/E-to-growth (PEG) basis, using the consensus forward estimate and our own long-term growth rate (no consensus LTGR is currently available). OZRK s P/E-to-growth (PEG) ratio on this basis is 1.03, a 29% discount to the 1.45 median for the peer group (vs. a 25% discount previously). On a price-to-book basis, however, the 42% premium looks fair given an ROE 55% above median (and falling). The quantitative Zacks Rank for OZRK is currently 4 (down from 3 on April 12), indicating some likelihood for downward pressure on the shares over the near term. Short interest remains extremely high at 54.1 days, though down from 59.5 days previously. Industry Comparables (small-cap banks) P/E using trailing 12 mo EPS P/E using 4 qtr Est 5 yr Avg trailing P/E Return on Equity Return on Assets Price/ Book Next 3-5 Yr Est EPS Gr rate Div Yield OZRK median average high low Our new $32 target assumes that the shares will trade at 3.34 projected book value six months out, which also equates to 13.6 times our own forward estimate at that time. Combined the dividend, this equates to a 7.3% expected total return over the period. BULL STORY OZRK remains a growth story among the banking universe, generating consistent growth in both revenue and earnings in recent years. The majority of this growth has come from its de novo branching strategy (embarked on in 1994). OZRK opened six new branches in 2005, expanded another, and replaced two temporary facilities with permanent ones. Management intends to continue this strategy in 2006, adding as many as 12 new offices (and replacing two more temporary facilities), three of which have been opened year-to-date. De novo branching is often an expensive way to grow, but OZRK has managed to grow tremendously in recent years while improving the firm s cost structure at the same time, with the efficiency ratio reaching a new record as recently as Q4. Management continues to reiterate its focus on profitable growth. This is often a stated goal, but OZRK remains a fairly rare example of demonstrable success. ROA and ROE remain well ahead of the peer medians, at roughly 1.55% and 22% over the last 12 months, respectively. Both loan growth and deposit growth improved significantly in Q2, with average balances up 23.2% and 25%, respectively, year-over-year. As was noted on the Q4 call, deposit strategy has turned more aggressive, and we might expect deposit growth rates in the mid-teens to low 20s (matching their general expectation for loan growth), with some related pressure on the margin. Variable rate loans remain a growing component of OZRK s portfolio, continuing to improve its rate positioning at the margin. Credit quality remains solid, with non-performing loans representing 0.18% of total loans at June 30, and an allowance equating to 5.5 times NPAs and 1.12% of total loans. Zacks Investment Research Page 3

4 BEAR STORY We believe that P/B generally acts as a constraining factor for the shares (typically among the highest P/B of all the small-cap banks we track), which could easily trade higher on a PEG basis. Given the lower ROE in Q2 and probably throughout 2006, we think that the decline in P/B was justified, though we expect it to be more stable going forward. Margin compression also remains a concern (for all the banks) in the near future. Compression continued in Q2, exceeding even the magnitude of the Q1 decline, with NIM falling another 23 bps sequentially to 3.61%. The primary culprit was again management s deposit initiative, as a number of deposit products were re-priced in late January. A flat yield curve and stiff competition certainly did not help. Further margin deterioration remains a possibility, though the magnitude should be less than in recent quarters (although we said the same thing last quarter). Concentration risk is also significant to OZRK. One example of this is in credit risk. OZRK saw significant deterioration in credit quality in late 2004 (with non-performing loans more than doubling as a percent of total loans during the course of one quarter) on the back of a single credit relationship. While not indicative of a downward trend, it highlights an aspect of concentration risk that exists in smaller institutions. OZRK faces other forms of concentration risk, in our view, with 80% of revenue from net interest income, 80% of loans based on real estate, and 95% of branches in Arkansas. PROJECTED INCOME STATEMENT & BALANCE SHEET Bank of the Ozarks, Inc. Income Statement and Balance Sheet (Dollars in millions, except EPS data) 12/02 12/03 12/04 12/05 12/06 E 12/07 E Net interest income Non-interest income Net revenue (not FTE) Loan loss provisions Non-interest expense Income taxes & other Zacks adjusted income before NRI GAAP net income Diluted EPS before NRI Reported EPS Loans & leases ,135 1,371 1,730 2,080 Investment securities Total assets 1,036 1,387 1,727 2,135 2,710 3,270 Deposits 790 1,062 1,380 1,592 2,050 2,540 Other liabilities Shareholders' equity Zacks Investment Research Page 4

5 HISTORICAL ZACKS RECOMMENDATIONS DISCLOSURES The analysts contributing to this report do not hold any shares of OZRK. Zacks EPS and revenue forecasts are not consensus forecasts. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts personal views as to the subject securities and issuers. Zacks certifies that no part of the analysts compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Because of individual objectives, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. This report is not to be construed as an offer or the solicitation of an offer to buy or sell the securities herein mentioned. Zacks or its officers, employees or customers may have a position long or short in the securities mentioned and buy or sell the securities from time to time. Zacks uses the following rating system for the securities it covers. Buy- Zacks expects that the subject company will outperform the broader U.S. equity market over the next one to two quarters. Hold- Zacks expects that the company will perform in line with the broader U.S. equity market over the next one to two quarters. Sell- Zacks expects the company will under perform the broader U.S. Equity market over the next one to two quarters. The current distribution of Zacks Ratings is as follows on the 1128 companies covered: Buy- 21.5%, Hold- 73.9%, Sell 4.5%. Data is as of midnight on the business day immediately prior to this publication. Zacks Investment Research Page 5

SVB Financial Group NEUTRAL ZACKS CONSENSUS ESTIMATES (SIVB-NASDAQ) SUMMARY

SVB Financial Group NEUTRAL ZACKS CONSENSUS ESTIMATES (SIVB-NASDAQ) SUMMARY January 02, 2015 SVB Financial Group Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 01/02/2015 Current Price (01/01/15) $116.07 Target Price $122.00 SUMMARY DATA (SIVB-NASDAQ)

More information

First Republic Bank NEUTRAL ZACKS CONSENSUS ESTIMATES (FRC-NYSE) SUMMARY

First Republic Bank NEUTRAL ZACKS CONSENSUS ESTIMATES (FRC-NYSE) SUMMARY March 06, 2015 First Republic Bank Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 04/14/2011 Current Price (03/05/15) $57.70 Target Price $61.00 52-Week High

More information

Cincinnati Financial Corp.

Cincinnati Financial Corp. February 06, 2015 Cincinnati Financial Corp. NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (02/05/15) $51.89 Target Price $54.00 (CINF-NASDAQ)

More information

Pitney Bowes Inc. (PBI-NYSE) Analyst Note

Pitney Bowes Inc. (PBI-NYSE) Analyst Note February 03, 2015 Pitney Bowes Inc. (PBI-NYSE) Analyst Note Current Recommendation Prior Recommendation Outperform Date of Last Change 05/01/2014 Current Price (02/02/15) $22.26 Target Price $23.00 NEUTRAL

More information

Equity Research. Beacon Roofing Supply, Inc. (BECN-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation

Equity Research. Beacon Roofing Supply, Inc. (BECN-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation Equity Research July 7, 2006 Mario Ricchio www.zacks.com 155 North Wacker Drive Chicago, IL 60606 Beacon Roofing Supply, Inc. (BECN-NSDQ) Current Recommendation Hold Prior Recommendation Buy Date of Last

More information

Cullen/Frost Bankers, Inc.

Cullen/Frost Bankers, Inc. December 26, 2014 Cullen/Frost Bankers, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 11/30/2001 Current Price (12/25/14) $70.74 Target Price $74.00

More information

SUMMARY. Risk Level *

SUMMARY. Risk Level * February 26, 2015 The Home Depot, Inc. Current Recommendation Earnings Update: Home Depot Tops Q4 Earnings & Revenues, Guides FY15 SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change

More information

Navigant Consulting Inc.

Navigant Consulting Inc. February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00

More information

Marathon Petroleum Corporation

Marathon Petroleum Corporation January 19, 2015 Marathon Petroleum Corporation (MPC-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/07/2014 Current Price (01/16/15) $77.56 Target

More information

Vistaprint N.V. NEUTRAL ZACKS CONSENSUS ESTIMATES (VPRT-NASDAQ) SUMMARY

Vistaprint N.V. NEUTRAL ZACKS CONSENSUS ESTIMATES (VPRT-NASDAQ) SUMMARY October 30, 2014 Vistaprint N.V. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/07/2013 Current Price (10/29/14) $55.06 Target Price $58.00 52-Week High

More information

Pentair plc NEUTRAL ZACKS CONSENSUS ESTIMATES (PNR-NYSE)

Pentair plc NEUTRAL ZACKS CONSENSUS ESTIMATES (PNR-NYSE) March 20, 2015 Pentair plc (PNR-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/12/2014 Current Price (03/19/15) $64.38 Target Price $68.00 52-Week

More information

(RHI-NYSE) SUMMARY. Risk Level *

(RHI-NYSE) SUMMARY. Risk Level * March 04, 2015 Robert Half International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2012 Current Price (03/03/15) $62.70 Target Price $66.00

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK CPKF: Third Quarter Results Justify CPKF s Recent 7% Dividend Increase

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK CPKF: Third Quarter Results Justify CPKF s Recent 7% Dividend Increase Small-Cap Research November 25, 2015 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 111 North Canal Street Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK

More information

Avery Dennison Corporation

Avery Dennison Corporation March 20, 2015 Avery Dennison Corporation Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/26/2013 Current Price (03/19/15) $53.00 Target Price $56.00 SUMMARY DATA

More information

CIT Group Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CIT-NYSE)

CIT Group Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CIT-NYSE) February 24, 2015 CIT Group Inc. (CIT-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/18/2015 Current Price (02/23/15) $46.13 Target Price $48.50

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK Small-Cap Research February 22, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF:

More information

Invesco Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (IVZ-NYSE)

Invesco Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (IVZ-NYSE) March 10, 2015 Invesco Ltd. (IVZ-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/03/2012 Current Price (03/09/15) $40.40 Target Price $42.00 52-Week

More information

Torchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY

Torchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY March 12, 2015 Torchmark Corp. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2006 Current Price (03/11/15) $53.41 Target Price $56.00 SUMMARY DATA (TMK-NYSE)

More information

AXIS Capital Holdings Ltd.

AXIS Capital Holdings Ltd. March 20, 2015 AXIS Capital Holdings Ltd. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/24/2013 Current Price (03/19/15) $51.45 Target Price $54.00

More information

The PNC Financial Services Group, Inc.

The PNC Financial Services Group, Inc. February 16, 2015 The PNC Financial Services Group, Inc. (PNC-NYSE) Current Recommendation Prior Recommendation Outperform Date of Last Change 05/04/2010 Current Price (02/13/15) $92.38 Target Price $97.00

More information

Prudential Financial Inc.

Prudential Financial Inc. February 06, 2015 Prudential Financial Inc. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 04/03/2014 Current Price (02/05/15) $75.32 Target Price $79.00 SUMMARY DATA

More information

Charter Communications Inc.

Charter Communications Inc. December 12, 2014 Charter Communications Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 02/26/2014 Current Price (12/11/14) $164.16 Target Price $172.00 SUMMARY

More information

Big Lots Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BIG-NYSE) SUMMARY

Big Lots Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BIG-NYSE) SUMMARY March 13, 2015 Big Lots Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 03/24/2014 Current Price (03/11/15) $49.95 Target Price $52.00 52-Week High

More information

Sallie Mae NEUTRAL ZACKS CONSENSUS ESTIMATES (SLM-NASDAQ)

Sallie Mae NEUTRAL ZACKS CONSENSUS ESTIMATES (SLM-NASDAQ) December 30, 2014 Sallie Mae (SLM-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/08/2013 Current Price (12/29/14) $10.32 Target Price $11.00

More information

Transocean Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (RIG-NYSE)

Transocean Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (RIG-NYSE) January 14, 2015 Transocean Ltd. (RIG-NYSE) Current Recommendation Prior Recommendation Underperform Date of Last Change 02/14/2012 Current Price (01/13/15) $15.52 Target Price $16.00 NEUTRAL SUMMARY We

More information

Dover Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (DOV-NYSE) SUMMARY

Dover Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (DOV-NYSE) SUMMARY March 09, 2015 Dover Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 01/11/2011 Current Price (03/06/15) $70.71 Target Price $74.00 NEUTRAL SUMMARY (DOV-NYSE) In

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK. CPKF: Spectacular Quarter with Diluted EPS Surging 32% Year over Year

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK. CPKF: Spectacular Quarter with Diluted EPS Surging 32% Year over Year Small-Cap Research June 15, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF: Spectacular

More information

Avnet, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (AVT-NYSE) SUMMARY

Avnet, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (AVT-NYSE) SUMMARY January 30, 2015 Avnet, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Underperform Date of Last Change 04/02/2013 Current Price (01/29/15) $42.26 Target Price $44.00 52-Week High

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target

More information

Itron, Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (ITRI-NASDAQ) SUMMARY

Itron, Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (ITRI-NASDAQ) SUMMARY February 13, 2015 Itron, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/08/2015 Current Price (02/12/15) $35.87 Target Price $33.00 SUMMARY DATA UNDERPERFORM 52-Week High

More information

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research May 15, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying

More information

The Cheesecake Factory Incorporated

The Cheesecake Factory Incorporated March 20, 2015 The Cheesecake Factory Incorporated (CAKE-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/12/2011 Current Price (03/19/15) $48.82

More information

Lincoln Electric Holdings Inc.

Lincoln Electric Holdings Inc. January 22, 2015 Lincoln Electric Holdings Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/22/2015 Current Price (01/21/15) $67.15 Target Price $81.00 OUTPERFORM SUMMARY

More information

Federated Investors, Inc.

Federated Investors, Inc. March 04, 2015 Federated Investors, Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 11/30/2014 Current Price (03/03/15) $33.52 Target Price $35.00 NEUTRAL SUMMARY (FII-NYSE)

More information

CRA International Inc.

CRA International Inc. February 27, 2015 CRA International Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 02/09/2015 Current Price (02/26/15) $30.11 Target Price $32.00 NEUTRAL (CRAI-NASDAQ)

More information

BancorpSouth, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BXS-NYSE) SUMMARY

BancorpSouth, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BXS-NYSE) SUMMARY December 22, 2014 BancorpSouth, Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 09/23/2013 Current Price (12/19/14) $22.12 Target Price $23.00 NEUTRAL SUMMARY (BXS-NYSE)

More information

The Tjx Companies Inc

The Tjx Companies Inc February 26, 2015 The Tjx Companies Inc Current Recommendation Prior Recommendation Underperform Date of Last Change 04/29/2010 Current Price (02/25/15) $69.38 Target Price $73.00 NEUTRAL SUMMARY (TJX-NYSE)

More information

Jones Lang LaSalle Inc.

Jones Lang LaSalle Inc. February 13, 2015 Jones Lang LaSalle Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 11/07/2013 Current Price (02/12/15) $160.97 Target Price $169.00

More information

Interpublic Group of Companies Inc.

Interpublic Group of Companies Inc. February 16, 2015 Interpublic Group of Companies Inc. (IPG-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 05/28/2012 Current Price (02/13/15) $22.10

More information

Cablevision Systems Corporation.

Cablevision Systems Corporation. January 14, 2015 Cablevision Systems Corporation. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (01/13/15) $20.00 Target Price

More information

American Capital Agency Corp.

American Capital Agency Corp. January 15, 2015 American Capital Agency Corp. (AGNC-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 10/15/2014 Current Price (01/14/15) $21.53 Target Price $26.00 SUMMARY

More information

Equity Residential NEUTRAL ZACKS CONSENSUS ESTIMATES (EQR-NYSE) SUMMARY

Equity Residential NEUTRAL ZACKS CONSENSUS ESTIMATES (EQR-NYSE) SUMMARY March 16, 2015 Equity Residential Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/15/2009 Current Price (03/13/15) $77.02 Target Price $81.00 52-Week

More information

TE Connectivity Ltd. (TEL-NYSE) Analyst Note

TE Connectivity Ltd. (TEL-NYSE) Analyst Note January 30, 2015 TE Connectivity Ltd. (TEL-NYSE) Analyst Note Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/30/2012 Current Price (01/29/15) $67.57

More information

Ultra Petroleum Corp.

Ultra Petroleum Corp. January 21, 2015 Ultra Petroleum Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 11/16/2014 Current Price (01/20/15) $13.57 Target Price $12.00 SUMMARY DATA UNDERPERFORM 52-Week

More information

Equity Research. Emergency Medical Services Corp (EMS-NYSE) EMS: Zacks Company Report - HOLD OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Equity Research. Emergency Medical Services Corp (EMS-NYSE) EMS: Zacks Company Report - HOLD OUTLOOK SUMMARY DATA ZACKS ESTIMATES Equity Research November 18, 2008 Chris Kallos www.zacks.com 111 North Canal Street, Chicago, IL 60606 Emergency Medical Services Corp EMS: Zacks Company Report - HOLD Current Recommendation Hold Prior

More information

Avon Products Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (AVP-NYSE)

Avon Products Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (AVP-NYSE) February 19, 2015 Avon Products Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $9.10 Target Price $8.25 SUMMARY DATA UNDERPERFORM 52-Week

More information

(SEIC-NASDAQ) Risk Level *

(SEIC-NASDAQ) Risk Level * March 20, 2015 SEI Investments Co. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/30/2013 Current Price (03/19/15) $43.74 Target Price $46.00 SUMMARY DATA (SEIC-NASDAQ)

More information

(PGR-NYSE) Risk Level *

(PGR-NYSE) Risk Level * March 18, 2015 Progressive Corp. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 05/19/2013 Current Price (03/17/15) $27.03 Target Price $28.00 SUMMARY DATA (PGR-NYSE)

More information

Genworth Financial Inc.

Genworth Financial Inc. February 12, 2015 Genworth Financial Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 08/22/2014 Current Price (02/11/15) $8.33 Target Price $7.50 SUMMARY DATA UNDERPERFORM

More information

Equity Research. Chemed Corporation (CHE-NYSE) CHE: Zacks Company Report - HOLD OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Equity Research. Chemed Corporation (CHE-NYSE) CHE: Zacks Company Report - HOLD OUTLOOK SUMMARY DATA ZACKS ESTIMATES Equity Research October 22, 2008 Chris Kallos www.zacks.com 111 North Canal Street, Chicago, IL 60606 Chemed Corporation (CHE-NYSE) CHE: Zacks Company Report - HOLD Current Recommendation Hold Prior Recommendation

More information

Deere & Company NEUTRAL ZACKS CONSENSUS ESTIMATES (DE-NYSE)

Deere & Company NEUTRAL ZACKS CONSENSUS ESTIMATES (DE-NYSE) February 13, 2015 Deere & Company Current Recommendation Prior Recommendation Outperform Date of Last Change 12/09/2010 Current Price (02/12/15) $89.37 Target Price $94.00 NEUTRAL (DE-NYSE) SUMMARY Deere

More information

Kirkland s Inc OUTPERFORM ZACKS CONSENSUS ESTIMATES (KIRK-NASDAQ) SUMMARY

Kirkland s Inc OUTPERFORM ZACKS CONSENSUS ESTIMATES (KIRK-NASDAQ) SUMMARY February 09, 2015 Kirkland s Inc (KIRK-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/09/2015 Current Price (02/06/15) $25.66 Target Price $31.00 OUTPERFORM SUMMARY

More information

CONSOL Energy Inc. (CNX-NYSE)

CONSOL Energy Inc. (CNX-NYSE) March 17, 2015 CONSOL Energy Inc. (CNX-NYSE) Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/20/2013 Current Price (03/16/15) $27.02 Target Price $28.00 SUMMARY

More information

CH Robinson Worldwide Inc.

CH Robinson Worldwide Inc. March 20, 2015 CH Robinson Worldwide Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/22/2013 Current Price (03/19/15) $75.16 Target Price $79.00 SUMMARY DATA

More information

Armstrong World Industries, Inc.

Armstrong World Industries, Inc. December 11, 2014 Armstrong World Industries, Inc. (AWI-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 08/24/2014 Current Price (12/10/14) $47.71 Target Price $43.00 SUMMARY

More information

Liberty Interactive Corporation

Liberty Interactive Corporation September 11, 2014 Liberty Interactive Corporation (LINTA-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 09/11/2014 Current Price (09/10/14) $29.41 Target Price $27.00

More information

Canadian Natural Resources Ltd.

Canadian Natural Resources Ltd. September 11, 2009 Canadian Natural Resources Ltd. SUMMARY DATA NEUTRAL Current Recommendation Prior Recommendation OUTPERFORM Date of Last Change 08/18/2009 Current Price (09/10/09) $62.91 Target Price

More information

SUMMARY. Risk Level *

SUMMARY. Risk Level * January 09, 2015 Fred s Inc (FRED-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 07/17/2014 Current Price (01/08/15) $17.13 Target Price $18.00

More information

The Clorox Company NEUTRAL ZACKS CONSENSUS ESTIMATES (CLX-NYSE)

The Clorox Company NEUTRAL ZACKS CONSENSUS ESTIMATES (CLX-NYSE) March 11, 2015 The Clorox Company Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 11/11/2012 Current Price (03/10/15) $107.83 Target Price $113.00 SUMMARY DATA (CLX-NYSE)

More information

Rockwell Automation Inc.

Rockwell Automation Inc. March 16, 2015 Rockwell Automation Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/31/2011 Current Price (03/13/15) $111.52 Target Price $117.00

More information

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc. January 21, 2015 Bed Bath & Beyond Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/23/2009 Current Price (01/20/15) $73.31 Target Price $77.00 52-Week

More information

(MOS-NYSE) Risk Level *

(MOS-NYSE) Risk Level * March 09, 2015 The Mosaic Company Current Recommendation Prior Recommendation Neutral Date of Last Change 03/09/2015 Current Price (03/06/15) $49.03 Target Price $59.00 OUTPERFORM (MOS-NYSE) SUMMARY We

More information

Hudson City Bancorp, Inc.

Hudson City Bancorp, Inc. March 20, 2015 Hudson City Bancorp, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 03/20/2015 Current Price (03/19/15) $10.31 Target Price $11.00 52-Week

More information

Companhia Paranaense De Energia

Companhia Paranaense De Energia January 21, 2015 Companhia Paranaense De Energia (ELP-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/21/2015 Current Price (01/20/15) $12.20

More information

Cabot Oil & Gas Corporation

Cabot Oil & Gas Corporation January 16, 2015 Cabot Oil & Gas Corporation Current Recommendation Prior Recommendation Neutral Date of Last Change 01/16/2015 Current Price (01/15/15) $28.78 Target Price $26.00 UNDERPERFORM SUMMARY

More information

AGCO Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (AGCO-NYSE) SUMMARY

AGCO Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (AGCO-NYSE) SUMMARY February 05, 2015 AGCO Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/28/2014 Current Price (02/03/15) $48.96 Target Price $51.00 52-Week

More information

Interactive Brokers Group, Inc.

Interactive Brokers Group, Inc. January 06, 2015 Interactive Brokers Group, Inc. (IBKR-NASDAQ) Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 07/08/2014 Current Price (01/05/15) $28.88 Target Price

More information

Wells Fargo & Company

Wells Fargo & Company March 04, 2015 Wells Fargo & Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation N/A Date of Last Change 04/07/2000 Current Price (03/03/15) $55.45 Target Price $58.00 52-Week High

More information

Dillard s Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (DDS-NYSE)

Dillard s Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (DDS-NYSE) March 12, 2015 Dillard s Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/05/2014 Current Price (03/11/15) $130.28 Target Price $137.00 52-Week High

More information

Terex Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (TEX-NYSE) SUMMARY

Terex Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (TEX-NYSE) SUMMARY February 19, 2015 Terex Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/04/2015 Current Price (02/18/15) $26.80 Target Price $28.00 52-Week

More information

SUMMARY. Risk Level *

SUMMARY. Risk Level * February 02, 2015 Xerox Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/18/2012 Current Price (01/30/15) $13.17 Target Price $14.00 52-Week

More information

3M Company NEUTRAL ZACKS CONSENSUS ESTIMATES (MMM-NYSE)

3M Company NEUTRAL ZACKS CONSENSUS ESTIMATES (MMM-NYSE) January 29, 2015 3M Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 04/27/2010 Current Price (01/28/15) $163.94 Target Price $172.00 52-Week High

More information

HSBC Holdings plc ADR (HSBC-NYSE)

HSBC Holdings plc ADR (HSBC-NYSE) February 24, 2015 HSBC Holdings plc ADR (HSBC-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 12/21/2014 Current Price (02/23/15) $44.68 Target Price

More information

O'Reilly Automotive Inc.

O'Reilly Automotive Inc. February 05, 2015 O'Reilly Automotive Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 06/15/2011 Current Price (02/03/15) $193.28 Target Price $203.00

More information

CONMED Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (CNMD-NASDAQ) SUMMARY

CONMED Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (CNMD-NASDAQ) SUMMARY January 29, 2015 CONMED Corporation Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 11/21/2012 Current Price (01/28/15) $47.14 Target Price $49.00 Earnings Update-

More information

Exelon Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (EXC-NYSE) SUMMARY

Exelon Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (EXC-NYSE) SUMMARY March 06, 2015 Exelon Corporation Current Recommendation Prior Recommendation NEUTRAL Underperform Date of Last Change 06/28/2009 Current Price (03/05/15) $32.97 Target Price $35.00 (EXC-NYSE) SUMMARY

More information

American Axle & Manufacturing Holdings Inc.

American Axle & Manufacturing Holdings Inc. January 22, 2015 American Axle & Manufacturing Holdings Inc. (AXL-NYSE) NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 05/07/2013 Current Price (01/21/15) $24.14 Target

More information

Simon Property Group Inc. (SPG-NYSE) Analyst Note

Simon Property Group Inc. (SPG-NYSE) Analyst Note February 02, 2015 Simon Property Group Inc. (SPG-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 09/11/2014 Current Price (01/30/15) $198.66 Target

More information

Mindray Medical International Limited

Mindray Medical International Limited January 22, 2015 Mindray Medical International Limited Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 06/26/2014 Current Price (01/21/15) $26.73 Target Price $28.00

More information

KB Home UNDERPERFORM ZACKS CONSENSUS ESTIMATES (KBH-NYSE)

KB Home UNDERPERFORM ZACKS CONSENSUS ESTIMATES (KBH-NYSE) February 11, 2015 KB Home (KBH-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/11/2015 Current Price (02/10/15) $13.61 Target Price $12.00 UNDERPERFORM SUMMARY We are downgrading

More information

SUMMARY. Risk Level *

SUMMARY. Risk Level * February 13, 2015 NetApp, Inc. Current Recommendation Earnings Update: NetApp Reports Q3 Results SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2013 Current Price (02/12/15)

More information

Snap-On Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES RECENT NEWS (SNA-NYSE) SUMMARY

Snap-On Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES RECENT NEWS (SNA-NYSE) SUMMARY February 09, 2015 Snap-On Inc. (SNA-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 09/26/2011 Current Price (02/06/15) $140.99 Target Price $148.00 SUMMARY Keeping

More information

Healthways Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (HWAY-NASDAQ) SUMMARY

Healthways Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (HWAY-NASDAQ) SUMMARY October 28, 2014 Healthways Inc. Current Recommendation Prior Recommendation Earnings Update SUMMARY DATA Healthways report Q3 OUTPERFORM Neutral Date of Last Change 08/06/2014 Current Price (10/27/14)

More information

Health Care REIT Inc.

Health Care REIT Inc. January 05, 2015 Health Care REIT Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2004 Current Price (01/02/15) $76.95 Target Price $81.00 52-Week

More information

Central Garden & Pet Company

Central Garden & Pet Company February 11, 2015 Central Garden & Pet Company (CENT-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 06/22/2014 Current Price (02/10/15) $9.13 Target

More information

athenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY

athenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY February 10, 2015 athenahealth Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 10/23/2011 Current Price (02/09/15) $136.28 Target Price $143.00 52-Week

More information

Symmetry Medical, Inc.

Symmetry Medical, Inc. November 28, 2014 Symmetry Medical, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/28/2014 Current Price (11/27/14) $9.11 Target Price $9.50 52-Week

More information

Meritor, Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (MTOR-NYSE)

Meritor, Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (MTOR-NYSE) January 08, 2015 Meritor, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/08/2015 Current Price (01/07/15) $15.10 Target Price $18.00 SUMMARY DATA OUTPERFORM 52-Week High

More information

NextEra Energy Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (NEE-NYSE)

NextEra Energy Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (NEE-NYSE) March 10, 2015 NextEra Energy Inc. Current Recommendation Prior Recommendation NEUTRAL Outperform Date of Last Change 01/14/2010 Current Price (03/09/15) $98.93 Target Price $104.00 (NEE-NYSE) SUMMARY

More information

Ubiquiti Networks, Inc.

Ubiquiti Networks, Inc. January 07, 2015 Ubiquiti Networks, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/07/ 2015 Current Price (01/06/15) $27.86 Target Price $25.00 UNDERPERFORM (UBNT-NASDAQ)

More information

Suncor Energy UNDERPERFORM ZACKS CONSENSUS ESTIMATES (SU-NYSE)

Suncor Energy UNDERPERFORM ZACKS CONSENSUS ESTIMATES (SU-NYSE) March 11, 2015 Suncor Energy (SU-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 12/18/2014 Current Price (03/10/15) $28.03 Target Price $25.00 UNDERPERFORM SUMMARY Amid weak

More information

McDermott International Inc.

McDermott International Inc. January 12, 2015 McDermott International Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 03/04/2013 Current Price (01/09/15) $2.85 Target Price $3.00 SUMMARY DATA

More information

Legg Mason Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (LM-NYSE)

Legg Mason Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (LM-NYSE) March 12, 2015 Legg Mason Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 09/22/2013 Current Price (03/11/15) $55.03 Target Price $58.00 52-Week High

More information

Akamai Technologies Inc.

Akamai Technologies Inc. February 19, 2015 Akamai Technologies Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 12/22/2013 Current Price (02/18/15) $70.29 Target Price $74.00 NEUTRAL SUMMARY (AKAM-NASDAQ)

More information

Small-Cap Research (SILC-NASDAQ) SILC: Growth Eludes Silicom for the Next Few Quarters- Downgrading to Hold OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research (SILC-NASDAQ) SILC: Growth Eludes Silicom for the Next Few Quarters- Downgrading to Hold OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research July 23, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Silicom Limited (SILC-NASDAQ) SILC: Growth Eludes Silicom for the

More information

Sinopec Shanghai Petrochemical Co. Ltd.

Sinopec Shanghai Petrochemical Co. Ltd. March 18, 2013 Sinopec Shanghai Petrochemical Co. Ltd. (SHI-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 06/10/2008 Current Price (03/15/13) $42.10 Target Price

More information

DENTSPLY International Inc.

DENTSPLY International Inc. March 18, 2015 DENTSPLY International Inc. Current Recommendation Prior Recommendation NEUTRAL Outperform Date of Last Change 02/19/2012 Current Price (03/17/15) $51.13 Target Price $54.00 SUMMARY (XRAY-NASDAQ)

More information

ZACKS CONSENSUS ESTIMATES

ZACKS CONSENSUS ESTIMATES March 06, 2015 VIVUS Inc. (VVUS-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 03/06/2015 Current Price (03/05/15) $2.87 Target Price $3.00 52-Week

More information

Precision Castparts Corp.

Precision Castparts Corp. February 19, 2015 Precision Castparts Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $210.97 Target Price $192.00 UNDERPERFORM (PCP-NYSE)

More information

VeriSign Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (VRSN-NASDAQ) SUMMARY

VeriSign Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (VRSN-NASDAQ) SUMMARY September 19, 2013 VeriSign Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 06/24/2013 Current Price (09/18/13) $51.30 Target Price $54.00 52-Week High

More information